KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Cash from Discontinued OperationsCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Non-cash Items (2016 - 2025)

Historic Non-cash Items for TherapeuticsMD (TXMD) over the last 15 years, with Q3 2025 value amounting to $949000.0.

  • TherapeuticsMD's Non-cash Items rose 187708.33% to $949000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 411458.33%. This contributed to the annual value of $3.5 million for FY2024, which is 466986.3% up from last year.
  • Latest data reveals that TherapeuticsMD reported Non-cash Items of $949000.0 as of Q3 2025, which was up 187708.33% from -$164000.0 recorded in Q2 2025.
  • In the past 5 years, TherapeuticsMD's Non-cash Items ranged from a high of $22.7 million in Q3 2021 and a low of -$18.2 million during Q4 2022
  • In the last 5 years, TherapeuticsMD's Non-cash Items had a median value of $24035.0 in 2024 and averaged $983615.0.
  • As far as peak fluctuations go, TherapeuticsMD's Non-cash Items plummeted by 223033.33% in 2023, and later soared by 190704285.71% in 2025.
  • TherapeuticsMD's Non-cash Items (Quarter) stood at -$2.1 million in 2021, then crashed by 748.09% to -$18.2 million in 2022, then soared by 81.23% to -$3.4 million in 2023, then surged by 97.16% to -$97000.0 in 2024, then soared by 1078.35% to $949000.0 in 2025.
  • Its last three reported values are $949000.0 in Q3 2025, -$164000.0 for Q2 2025, and $1.3 million during Q1 2025.